Literature DB >> 32711023

Cardiomyocyte specific deletion of p53 decreases cell injury during ischemia-reperfusion: Role of Mitochondria.

Qun Chen1, Jeremy Thompson2, Ying Hu2, Edward J Lesnefsky3.   

Abstract

p53 is a tumor suppressor protein with a very low content in the basal condition, but the content rapidly rises during stress conditions including ischemia-reperfusion. An increase in p53 content increases cardiac injury during ischemia-reperfusion. Since mitochondrial damage plays a key role in cardiac injury during ischemia-reperfusion, we asked if genetic ablation of p53 decreases cardiac injury by protecting mitochondria. Isolated, perfused hearts from cardiac specific p53 deletion or wild type underwent 25 min global ischemia at 37 °C and 60 min reperfusion. At the end of reperfusion, hearts were harvested for infarct size measurement. In separate groups, cardiac mitochondria were isolated at 30 min reperfusion. Time control hearts were buffer-perfused without ischemia. Compared to wild type, deletion of p53 improved cardiac functional recovery and decreased infarct size following ischemia-reperfusion. Oxidative phosphorylation was improved in p53 deletion mitochondria following ischemia-reperfusion compared to wild type. The net release of ROS generation from wild type but not in p53 deletion mitochondria was increased following ischemia-reperfusion. Peroxiredoxin 3 (PRDX 3) content was higher in p53 deletion than that in wild type, indicating that p53 deletion increases a key antioxidant. Ischemia-reperfusion led to increased spectrin cleavage (a marker of cytosolic calpain1 activation) in wild type but not in p53 deletion mice. Ischemia-reperfusion increased the truncation of mature AIF (apoptosis inducing factor, an indicator of mitochondrial calpain1 activation) in wild type but not in p53 deletion mice. The loss of cytochrome c from mitochondria was also decreased in p53 deletion following ischemia-reperfusion. Bcl-2 content was decreased in wild type but not in p53 deletion following reperfusion, suggesting that depletion of bcl-2 contributes to permeabilization of the mitochondrial outer membrane. Thus, deletion of p53 decreases cardiac injury by protecting mitochondria through attenuation of oxidative stress and calpain activation during ischemia-reperfusion.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Mitochondria; Mitochondrial permeability transition pore; Peroxiredoxins; Reactive oxygen species

Mesh:

Substances:

Year:  2020        PMID: 32711023      PMCID: PMC7484321          DOI: 10.1016/j.freeradbiomed.2020.06.006

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  73 in total

1.  Myocardial ischemia decreases oxidative phosphorylation through cytochrome oxidase in subsarcolemmal mitochondria.

Authors:  E J Lesnefsky; B Tandler; J Ye; T J Slabe; J Turkaly; C L Hoppel
Journal:  Am J Physiol       Date:  1997-09

2.  Calpain translocation and activation as pharmacological targets during myocardial ischemia/reperfusion.

Authors:  Víctor Hernando; Javier Inserte; Carmem Luíza Sartório; Víctor M Parra; Marcos Poncelas-Nozal; David Garcia-Dorado
Journal:  J Mol Cell Cardiol       Date:  2010-03-06       Impact factor: 5.000

3.  Blockade of electron transport during ischemia preserves bcl-2 and inhibits opening of the mitochondrial permeability transition pore.

Authors:  Qun Chen; Edward J Lesnefsky
Journal:  FEBS Lett       Date:  2011-02-25       Impact factor: 4.124

4.  p21 protects cardiomyocytes against ischemia-reperfusion injury by inhibiting oxidative stress.

Authors:  Hong Li; Tong Zou; Shuai Meng; Yun-Zhu Peng; Jie-Fu Yang
Journal:  Mol Med Rep       Date:  2018-01-05       Impact factor: 2.952

5.  Mitochondrial-targeted Signal transducer and activator of transcription 3 (STAT3) protects against ischemia-induced changes in the electron transport chain and the generation of reactive oxygen species.

Authors:  Karol Szczepanek; Qun Chen; Marta Derecka; Fadi N Salloum; Qifang Zhang; Magdalena Szelag; Joanna Cichy; Rakesh C Kukreja; Jozef Dulak; Edward J Lesnefsky; Andrew C Larner
Journal:  J Biol Chem       Date:  2011-06-29       Impact factor: 5.157

Review 6.  What is the mitochondrial permeability transition pore?

Authors:  Andrew P Halestrap
Journal:  J Mol Cell Cardiol       Date:  2009-03-03       Impact factor: 5.000

7.  Cardioprotective Effect of Modified Peroxiredoxins in Retrograde Perfusion of Isolated Rat Heart under Conditions of Oxidative Stress.

Authors:  E V Karaduleva; E K Mubarakshina; M G Sharapov; A E Volkova; O Yu Pimenov; V K Ravin; Yu M Kokoz; V I Novoselov
Journal:  Bull Exp Biol Med       Date:  2016-03-29       Impact factor: 0.804

8.  Transient complex I inhibition at the onset of reperfusion by extracellular acidification decreases cardiac injury.

Authors:  Aijun Xu; Karol Szczepanek; Michael W Maceyka; Thomas Ross; Elizabeth Bowler; Ying Hu; Barrett Kenny; Chris Mehfoud; Pooja N Desai; Clive M Baumgarten; Qun Chen; Edward J Lesnefsky
Journal:  Am J Physiol Cell Physiol       Date:  2014-04-02       Impact factor: 4.249

9.  Inhibition of Bcl-2 sensitizes mitochondrial permeability transition pore (MPTP) opening in ischemia-damaged mitochondria.

Authors:  Qun Chen; Haishan Xu; Aijun Xu; Thomas Ross; Elizabeth Bowler; Ying Hu; Edward J Lesnefsky
Journal:  PLoS One       Date:  2015-03-10       Impact factor: 3.240

10.  ARC regulates programmed necrosis and myocardial ischemia/reperfusion injury through the inhibition of mPTP opening.

Authors:  Tao Xu; Wei Ding; Xiang Ao; Xianming Chu; Qinggong Wan; Yu Wang; Dandan Xiao; Wanpeng Yu; Mengyang Li; Fei Yu; Jianxun Wang
Journal:  Redox Biol       Date:  2018-11-02       Impact factor: 11.799

View more
  4 in total

1.  Integrated Gut-Heart Axis and Network Pharmacology to Reveal the Mechanisms of the Huoxue Wentong Formula Against Myocardial Ischemia.

Authors:  Jianguo Lin; Qingqing Wang; Xin Hua; Jinlong Duan; Kuiwu Yao
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-11       Impact factor: 2.650

Review 2.  Preventing Myocardial Injury Following Non-Cardiac Surgery: A Potential Role for Preoperative Antioxidant Therapy with Ubiquinone.

Authors:  Qun Chen; Steven Qi; Laura Hocum-Stone; Edward Lesnefsky; Rosemary F Kelly; Edward O McFalls
Journal:  Antioxidants (Basel)       Date:  2021-02-10

Review 3.  Regulation of Mitochondrial Quality Control by Natural Drugs in the Treatment of Cardiovascular Diseases: Potential and Advantages.

Authors:  Xing Chang; Wenjin Zhang; Zhenyu Zhao; Chunxia Ma; Tian Zhang; Qingyan Meng; Peizheng Yan; Lei Zhang; Yuping Zhao
Journal:  Front Cell Dev Biol       Date:  2020-12-23

4.  Targeted inhibition of calpain in mitochondria alleviates oxidative stress-induced myocardial injury.

Authors:  Dong Zheng; Ting Cao; Lu-Lu Zhang; Guo-Chang Fan; Jun Qiu; Tian-Qing Peng
Journal:  Acta Pharmacol Sin       Date:  2020-09-23       Impact factor: 7.169

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.